Calumet (CLMT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
18 May, 2026Executive summary
Achieved $4.2 billion in revenue for 2024, with a 23% increase in stock price and a 67% total 3-year shareholder return.
Completed conversion from a Master Limited Partnership to a C-Corporation in July 2024.
Montana Renewables received $782 million from the DOE, supporting expansion to become a leading global SAF producer.
Sold Royal Purple® industrial assets for $105 million and achieved record operational and safety milestones.
Specialties and Performance Brands segments posted record sales and volume growth in 2024.
Voting matters and shareholder proposals
Four Class I directors nominated for election to serve until 2028; two are new nominees.
Advisory vote to approve executive compensation and on the frequency of future say-on-pay votes (Board recommends annual vote).
Ratification of Grant Thornton LLP as independent auditor for 2025.
Only stockholders of record as of April 14, 2025, are entitled to vote.
Board of directors and corporate governance
Board consists of 10 directors, with 8 out of 10 being independent and 4 women.
Board divided into three classes with staggered terms; Heritage Group retains nomination rights based on ownership.
Five standing committees: Audit, Compensation, Governance, Risk, and Strategy & Growth, all with defined charters.
Annual board and committee self-evaluations; no stockholder rights plan in place.
Latest events from Calumet
- Board refreshed, financials strong, and all proposals approved as growth initiatives advance.CLMT
AGM 20262 Jun 2026 - 2025 saw strong revenue, debt reduction, and major renewables growth; board urges support for all proposals.CLMT
Proxy filing18 May 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.CLMT
Proxy filing18 May 2026 - Q3 2025 net income surged to $313.4M, with record EBITDA and SAF expansion progress.CLMT
Q3 202518 May 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.CLMT
Proxy filing18 May 2026 - Q1 2026 Adjusted EBITDA with Tax Attributes was $50.1M; expansion and supply deals support growth.CLMT
Q1 202618 May 2026 - Adjusted EBITDA up 30% to $293.3M, $222M debt cut, and record specialty output achieved.CLMT
Q4 20257 Apr 2026 - Expanding SAF production and strong cash flow drive growth, supported by regulatory tailwinds.CLMT
H.C. Wainwright Renewables Fuels Virtual Day presentation25 Mar 2026 - Q2 2024 delivered $66.8M EBITDA, record volumes, and C-Corp conversion amid margin pressure.CLMT
Q2 20241 Feb 2026